Despite these encouraging results, a treatment with single chemokine antagonist will not be enough to suppress metastatic tumor growth since even total deletion of CCR1, CCR2, or CCR5 by knockout cannot achieve complete elimination of metastatic tumors in mouse models (42, 86). This evidence concerns the gene CCR2 and neoplasm.